Description

Jakavi 15mg Tablet (Ruxolitinib) – Uses, Side Effects, Dosage & Price in Pakistan

Jakavi 15mg Tablet (Ruxolitinib) is a prescription medicine containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is used for certain blood and bone marrow disorders, including myelofibrosis and polycythaemia vera, and also has approved uses in certain patients with graft-versus-host disease (GvHD).

Ruxolitinib works by reducing abnormal signalling through Janus kinase pathways involved in blood-cell production and immune activity. Because this medicine can affect blood-cell counts and immune function, treatment should be started and monitored by a healthcare professional experienced in the use of anticancer medicines.

Patients searching for Jakavi 15mg Tablet in Pakistan should use it only according to their specialist’s prescription. The appropriate strength and dose depend on the condition being treated, platelet count, blood-test results, other medicines and individual response.

Jakavi 15mg Tablet (Ruxolitinib) Uses

Jakavi has several important approved medical uses.

Myelofibrosis

Ruxolitinib is used in adults with certain forms of myelofibrosis, including primary myelofibrosis and myelofibrosis occurring after polycythaemia vera or essential thrombocythaemia.

Myelofibrosis affects normal blood-cell production in the bone marrow and can lead to symptoms such as:

• Enlarged spleen
• Tiredness
• Night sweats
• Fever
• Bone pain
• Weight loss

Treatment can help control disease-related splenomegaly and symptoms in appropriate patients.

Polycythaemia Vera

Jakavi is also used for polycythaemia vera (PV) in adults when hydroxyurea does not work adequately or causes unacceptable side effects.

Polycythaemia vera causes excessive production of red blood cells. This can make the blood thicker and contribute to complications.

Graft-Versus-Host Disease

Ruxolitinib also has approved uses for certain patients with acute or chronic graft-versus-host disease when corticosteroids or other systemic treatments have not produced an adequate response.

GvHD can occur after an allogeneic stem-cell transplant when donated immune cells attack the recipient’s tissues.

How Does Ruxolitinib Work?

Ruxolitinib inhibits Janus-associated kinases, particularly signalling pathways involving JAK1 and JAK2.

These enzymes participate in signals that regulate blood-cell production, inflammation and immune-system activity.

In myelofibrosis and polycythaemia vera, abnormal JAK signalling contributes to excessive or abnormal blood-cell production. By reducing this signalling, ruxolitinib can help control disease-related effects and symptoms.

JAK signalling also participates in immune responses involved in graft-versus-host disease. Blocking these pathways can therefore reduce inappropriate inflammatory activity in suitable patients.

Jakavi 15mg Tablet Dosage

The appropriate Jakavi 15mg Tablet (Ruxolitinib) dosage depends on the condition being treated and the patient’s laboratory results.

For myelofibrosis, the recommended starting dose is determined partly by platelet count. For example, official European product information lists 15mg twice daily as a starting dose for certain adults with platelet counts between 100,000 and 200,000/mm³.

However, this does not mean that every patient should take 15mg twice daily.

Other strengths and doses may be appropriate depending on platelet count, treatment indication, kidney or liver function, drug interactions and adverse effects.

The dose may need to be reduced or treatment temporarily interrupted if blood-cell counts become too low.

Never change your ruxolitinib dose without your specialist’s instructions.

How to Take Jakavi

Take the medicine exactly as prescribed by your healthcare professional.

Jakavi tablets are generally administered twice daily and may be taken with or without food according to official product information.

Try to take each dose consistently according to your prescribed schedule.

Do not:

• Increase the dose yourself
• Take extra tablets for faster results
• Share the medicine with another patient
• Change between tablet strengths without medical advice
• Suddenly discontinue treatment unless instructed by your doctor

If treatment needs to be stopped, the treating specialist will determine the appropriate approach.

Jakavi 15mg Tablet Side Effects

Like other anticancer medicines, Jakavi 15mg Tablet (Ruxolitinib) can cause side effects.

Important effects can include changes in blood-cell counts, such as:

• Anaemia – reduced red blood cells
• Thrombocytopenia – reduced platelets
• Neutropenia – reduced neutrophils

Other reported effects can include:

• Dizziness
• Headache
• Bruising
• Bleeding
• Increased cholesterol or triglycerides
• Increased liver enzymes
• Weight gain in some treatment settings
• Infections

The side-effect profile can vary according to the condition being treated.

Regular laboratory monitoring is therefore an important part of ruxolitinib treatment.

Blood Tests During Treatment

A complete blood count (CBC) should be checked before treatment begins.

Blood counts are also monitored regularly after treatment starts. During initial dose adjustment, monitoring may be required relatively frequently.

This helps the treating specialist identify decreases in:

• Red blood cells
• Platelets
• Neutrophils and other white blood cells

Depending on the results, the doctor may continue treatment, reduce the dose, temporarily interrupt therapy or provide additional treatment.

Patients should not skip recommended blood tests simply because they feel well.

Infection Risk

Because ruxolitinib affects immune-system signalling, serious infections can occur.

Before starting treatment, healthcare professionals should evaluate relevant infection risks.

Patients should promptly report symptoms such as:

• Persistent fever
• Chills
• Severe weakness
• Persistent cough
• Painful skin rash
• Unusual infections
• Other signs of significant illness

Doctors may also assess patients for certain previous or latent infections when clinically appropriate.

Do not attempt to treat a serious infection by stopping or changing Jakavi independently. Contact your treating healthcare professional.

Precautions and Warnings

Before taking Jakavi, tell your healthcare professional about your complete medical history.

Particular attention may be necessary if you:

• Have an active or recurrent infection
• Have low blood-cell counts
• Have kidney impairment
• Have liver impairment
• Have previously had tuberculosis
• Take medicines that affect ruxolitinib metabolism
• Have other significant medical conditions

Your specialist should also know about all prescription medicines, over-the-counter products, herbal products and supplements you currently use.

Drug Interactions

Ruxolitinib is metabolised through pathways that can be affected by other medicines.

Certain medicines that strongly affect CYP3A4 or related metabolic pathways can alter ruxolitinib exposure.

Depending on the interacting medicine, the doctor may need to adjust the Jakavi dose or monitor the patient more closely.

Always provide your healthcare professional with a complete medication list before starting treatment.

Do not add or stop another prescription medicine without discussing possible interactions with your doctor or pharmacist.

Pregnancy and Breastfeeding

Pregnancy should be discussed carefully with the treating specialist.

According to current European product information, Jakavi should not be used during pregnancy, and appropriate contraception is important for women who could become pregnant during treatment.

Breastfeeding is also contraindicated during treatment according to the European product information.

Patients who are pregnant, planning pregnancy or breastfeeding should tell their healthcare professional before treatment.

CanJakavi 15mg Tablet (Ruxolitinib) Be Stopped Suddenly?

Patients should not stop ruxolitinib independently.

After discontinuation, symptoms related to the underlying disease may return. In some situations, healthcare professionals may consider gradual dose reduction when treatment is being discontinued for reasons other than certain blood-count problems.

The decision to reduce or stop treatment should therefore be made by the treating specialist.

Jakavi 15mg Tablet Price in Pakistan

The Jakavi 15mg Tablet price in Pakistan can vary according to pack size, supplier, imported stock, exchange rates and market availability.

Because specialty medicine prices can change considerably, using an old fixed price may give customers inaccurate information.

Patients and caregivers can contact Impo Medic to check the latest Jakavi 15mg price and current availability in Pakistan.

Always confirm the exact strength before purchasing because ruxolitinib tablets are available in multiple strengths.

Jakavi 15mg Tablet Availability in Pakistan

Availability of specialty medicines may differ between pharmacies and suppliers.

Customers searching for Jakavi 15mg Tablet (Ruxolitinib) in Pakistan can contact Impo Medic to inquire about current stock and sourcing information.

Before purchasing, confirm:

• Product name
• 15mg strength
• Pack size
• Packaging condition
• Expiry date
• Prescription requirements

Because Jakavi is a specialist prescription medicine, treatment should remain under the supervision of an experienced healthcare professional.

How to Buy Jakavi 15mg Tablet in Pakistan

Patients who have been prescribed Jakavi 15mg Tablet (Ruxolitinib) can contact Impo Medic for information about availability and current pricing in Pakistan.

When making an inquiry, provide the exact medicine name, strength and required quantity.

Do not substitute another ruxolitinib strength simply because the prescribed strength is temporarily unavailable. Dose changes should only be made by the treating specialist.

Follow applicable prescription requirements when purchasing this medicine.

Why Choose Impo Medic?

Impo Medic helps customers in Pakistan find information about local, imported and specialty medicines, including products used for complex blood disorders and other specialist conditions.

Patients or caregivers searching for Jakavi can contact Impo Medic for information regarding price in Pakistan, current availability, pack details and sourcing options.

Impo Medic aims to make medicine-related information easier to access while encouraging customers to follow prescriptions, specialist advice and appropriate medical monitoring.

Storage Instructions

Store Jakavi according to the manufacturer’s instructions provided on the original packaging.

Keep tablets protected from unsuitable heat, moisture and other inappropriate storage conditions.

Keep all medicines out of the reach of children.

Do not use tablets after their expiry date or if the packaging is damaged or appears suspicious.

FAQs About Jakavi 15mg Tablet (Ruxolitinib)

What is Jakavi 15mg Tablet (Ruxolitinib) used for?

Jakavi is used for certain patients with myelofibrosis, polycythaemia vera and graft-versus-host disease. The exact indication depends on the patient’s condition and previous treatment.

Is Jakavi a chemotherapy medicine?

Ruxolitinib is classified as a targeted JAK inhibitor/protein kinase inhibitor rather than traditional cytotoxic chemotherapy.

How does ruxolitinib work?

It inhibits Janus kinase signalling involved in blood-cell production and immune activity. This helps control abnormal signalling associated with conditions such as myelofibrosis, polycythaemia vera and GvHD.

Is Jakavi 15mg taken once or twice daily?

Jakavi is commonly administered twice daily, but the exact dose and strength depend on the disease, platelet count, laboratory results and other clinical factors. Follow your specialist’s prescription.

Can Jakavi cause low platelets?

Yes. Thrombocytopenia, or a reduction in platelets, is an important known adverse effect. Regular complete blood counts are required during treatment.

Can Jakavi cause anaemia?

Yes. Anaemia is a common and clinically important effect associated with ruxolitinib treatment. Blood counts should be monitored.

Does Jakavi increase infection risk?

Ruxolitinib affects immune signalling, and infections can occur. Patients should report fever or other significant signs of infection promptly.

Can I stop Jakavi when I feel better?

Do not discontinue treatment without consulting your specialist. Disease-related symptoms can return after stopping ruxolitinib, and the doctor should decide how treatment is changed or discontinued.

What is the Jakavi 15mg Tablet price in Pakistan?

The price varies according to supplier, pack size and stock availability. Contact Impo Medic to check current Jakavi 15mg pricing information in Pakistan.

Where can I buy Jakavi 15mg Tablet in Pakistan?

Patients with an appropriate prescription can contact Impo Medic to inquire about current availability and sourcing information in Pakistan.